Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 77

1.

The Impact of Proton Pump Inhibition on Dabigatran Levels in Patients With Atrial Fibrillation.

Bolek T, Samoš M, Stančiaková L, Ivanková J, Škorňová I, Staško J, Galajda P, Kubisz P, Mokáň M.

Am J Ther. 2017 Apr 25. doi: 10.1097/MJT.0000000000000599. [Epub ahead of print]

PMID:
28452843
2.

Expression of pattern recognition receptors and activation of the non-canonical inflammasome pathway in brain pericytes.

Nyúl-Tóth Á, Kozma M, Nagyőszi P, Nagy K, Fazakas C, Haskó J, Molnár K, Farkas AE, Végh AG, Váró G, Galajda P, Wilhelm I, Krizbai IA.

Brain Behav Immun. 2017 Apr 18. pii: S0889-1591(17)30112-5. doi: 10.1016/j.bbi.2017.04.010. [Epub ahead of print]

PMID:
28432035
3.

Review of the pharmacology of the emerging possibilities of the direct oral anticoagulants' reversal.

Samos M, Stanciakova L, Skornova I, Bolek T, Kovar F, Stasko J, Galajda P, Mokan M, Kubisz P.

Curr Drug Metab. 2017 Apr 13. doi: 10.2174/1389200218666170413155351. [Epub ahead of print]

PMID:
28412907
4.

Monitoring the hemostasis with rotation thromboelastometry in patients with acute STEMI on dual antiplatelet therapy: First experiences.

Samoš M, Stančiaková L, Duraj L, Kovář F, Fedor M, Šimonová R, Bolek T, Galajda P, Staško J, Kubisz P, Mokáň M.

Medicine (Baltimore). 2017 Feb;96(6):e6045. doi: 10.1097/MD.0000000000006045.

5.

Incidence of Diabetes Mellitus After Kidney Transplantation in Slovakia: Multicentric, Prospective Analysis.

Dedinská L, Baltesová T, Beňa Ĺ, Čellár M, Galajda P, Chrastina M, Jurčina A, Kováčiková L, Laca L, Lacková E, Lauková Valachová S, Miklušica J, Rosenberger J, Sersenová M, Skalová P, Žilinská Z, Mokáň M.

Transplant Proc. 2016 Dec;48(10):3292-3298. doi: 10.1016/j.transproceed.2016.09.041.

PMID:
27931571
6.

Correlation between CMV Infection and Post-transplantation New-onset Diabetes Mellitus.

Dedinská I, Laca Ľ, Miklušica J, Kantárová D, Galajda P, Mokáň M.

Int J Organ Transplant Med. 2016;7(3):173-182. Epub 2016 Aug 1.

7.

Treatment of Ormond Disease and Idiopathic Membranous Glomerulonephritis by using Rituximab.

Dedinská I, Svetlík D, Adamicova K, Machalekova K, Makovicky P, Jezikova A, Laca L, Miklusica J, Galajda P, Mokan M.

Iran J Kidney Dis. 2016 Sep;10(5):332-335.

8.

Sensing photosynthetic herbicides in an electrochemical flow cell.

Szabó T, Csekő R, Hajdu K, Nagy K, Sipos O, Galajda P, Garab G, Nagy L.

Photosynth Res. 2017 May;132(2):127-134. doi: 10.1007/s11120-016-0314-2. Epub 2016 Oct 5.

PMID:
27709414
9.

The Impact of Type 2 Diabetes on the Efficacy of ADP Receptor Blockers in Patients with Acute ST Elevation Myocardial Infarction: A Pilot Prospective Study.

Samoš M, Fedor M, Kovář F, Galajda P, Bolek T, Stančiaková L, Fedorová J, Staško J, Kubisz P, Mokáň M.

J Diabetes Res. 2016;2016:2909436. doi: 10.1155/2016/2909436. Epub 2016 Jul 17.

10.

[Acute causes of sudden deaths in patients with severe hypoglycemia].

Bolek T, Samoš M, Mokáň M, Galajda P, Mokáň M.

Vnitr Lek. 2016 Summer;62(6):462-6. Czech.

PMID:
27485844
11.

Heparin-induced Thrombocytopenia Presenting With Deep Venous Thrombosis and Pulmonary Embolism Successfully Treated With Rivaroxaban: Clinical Case Report and Review of Current Experiences.

Samoš M, Bolek T, Ivanková J, Stančiaková L, Kovář F, Galajda P, Kubisz P, Staško J, Mokáň M.

J Cardiovasc Pharmacol. 2016 Nov;68(5):391-394.

PMID:
27464495
12.

Does Pantoprazole Affect the On-Treatment Platelet Reactivity in Patients With Acute STEMI Treated With ADP Receptor Blockers?-A Pilot Prospective Study.

Bolek T, Samoš M, Šimonová R, Kovář F, Fedor M, Galajda P, Staško J, Kubisz P, Mokáň M.

Am J Ther. 2017 Mar/Apr;24(2):e162-e166. doi: 10.1097/MJT.0000000000000454.

PMID:
27415979
13.

Metabolic syndrome and new onset diabetes after kidney transplantation.

Dedinská I, Palkoci B, Miklušica J, Osinová D, Galajda P, Mokáň M.

Diabetes Metab Syndr. 2016 Jun 23. pii: S1871-4021(16)30061-3. doi: 10.1016/j.dsx.2016.06.027. [Epub ahead of print]

PMID:
27381969
14.

[Non usual cases of hypoglycaemia--hypoglycaemia factitia].

Mokán M, Galajda P, Mokán M.

Vnitr Lek. 2015 Dec;61(12 Suppl 5):5S45-9. Slovenian.

PMID:
27124972
15.

Type 2 Diabetes and ADP Receptor Blocker Therapy.

Samoš M, Fedor M, Kovář F, Mokáň M, Bolek T, Galajda P, Kubisz P, Mokáň M.

J Diabetes Res. 2016;2016:6760710. doi: 10.1155/2016/6760710. Epub 2015 Dec 28. Review.

16.

[Non usual cases of hypoglycaemia - hypoglycaemia factitia].

Mokáň M, Galajda P, Mokáň M.

Vnitr Lek. 2015;61 Suppl 5:45-9. Czech.

PMID:
26800473
17.

The Intricate Network of Adipokines and Stroke.

Kantorová E, Jesenská Ľ, Čierny D, Zeleňák K, Sivák Š, Stančík M, Galajda P, Nosáľ V, Kurča E.

Int J Endocrinol. 2015;2015:967698. doi: 10.1155/2015/967698. Epub 2015 Dec 10. Review.

18.

Transmigration characteristics of breast cancer and melanoma cells through the brain endothelium: Role of Rac and PI3K.

Molnár J, Fazakas C, Haskó J, Sipos O, Nagy K, Nyúl-Tóth Á, Farkas AE, Végh AG, Váró G, Galajda P, Krizbai IA, Wilhelm I.

Cell Adh Migr. 2016 May 3;10(3):269-81. doi: 10.1080/19336918.2015.1122156. Epub 2015 Dec 8.

19.

Ticagrelor: a safe and effective approach for overcoming clopidogrel resistance in patients with stent thrombosis?

Samoš M, Fedor M, Kovář F, Duraj L, Stančiaková L, Galajda P, Staško J, Kubisz P, Mokáň M.

Blood Coagul Fibrinolysis. 2016 Mar;27(2):117-20. doi: 10.1097/MBC.0000000000000406. Review.

PMID:
26340464
20.

Microfluidic study of the chemotactic response of Escherichia coli to amino acids, signaling molecules and secondary metabolites.

Nagy K, Sipos O, Valkai S, Gombai É, Hodula O, Kerényi Á, Ormos P, Galajda P.

Biomicrofluidics. 2015 Jul 15;9(4):044105. doi: 10.1063/1.4926981. eCollection 2015 Jul.

Supplemental Content

Loading ...
Support Center